Skip to main content
Repare Therapeutics Inc. logo

Repare Therapeutics Inc. — Investor Relations & Filings

Ticker · RPTX ISIN · US7602731025 US Professional, scientific and technical activities
Filings indexed 420 across all filing types
Latest filing 2026-01-30 Major Shareholding Noti…
Country US United States of America
Listing US RPTX

About Repare Therapeutics Inc.

https://www.reparerx.com/

Repare Therapeutics Inc. is a clinical-stage precision oncology company that develops novel medicines using a proprietary synthetic lethality approach. The company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies. This platform supports a pipeline of product candidates aimed at treating cancers with specific genetic alterations and addressing high unmet medical needs.

Recent filings

Filing Released Lang Actions
SCHEDULE 13D/A Filing
Major Shareholding Notification
2026-01-30 English
4 Filing
Director's Dealing
2026-01-30 English
S-8 POS Filing
Regulatory Filings
2026-01-28 English
S-8 POS Filing
Regulatory Filings
2026-01-28 English
4 Filing
Director's Dealing
2026-01-28 English
S-8 POS Filing
Regulatory Filings
2026-01-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.